Lupin’s product is the generic version of Pennsaid. (Representational)New Delhi: Drug firm Lupin today said it has launched a generic version of Pennsaid, used to treat pain in the knees caused by osteoarthritis in the American market.The company’s product — Diclofenac Sodium Topical Solution 2 per cent — is the generic version of Horizon Pharma Therapeutics Pennsaid, Lupin said in a statement.As per IQVIA MAT October 2022 data, Lupin said diclofenac sodium topical solution, 2 per cent, had estimated annual sales of $509 million in the US.(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)Featured Video Of The DayRBI Hikes Rates By A More Modest 0.35% To 6.25%, Cites Slowing Inflation
Source link